Koltan names Frank Karbe to board
This article was originally published in Scrip
Executive Summary
New Haven, Connecticut-based Koltan Pharmaceuticals has named Frank Karbe, former chief financial officer of Exelixis, to its board of directors. Mr Karbe has more than two decades of international experience in finance and business development. Previously, Mr Karbe held various positions in the finance department of The Royal Dutch/Shell Group in Europe. And since January 2010, he has been a member of the board and chair of the audit committee for Tekmira Pharmaceuticals, a publicly held biopharmaceutical company.